These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7174860)

  • 21. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study.
    Jankovic J
    Ann Neurol; 1982 Jan; 11(1):41-7. PubMed ID: 6460467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of metoclopramide hydrochloride in patients with residual schizophrenia with tardive dyskinesias].
    Kiehl U; Nitzsche M; Fischer GJ
    Psychiatr Neurol Med Psychol (Leipz); 1985 Dec; 37(12):722-6. PubMed ID: 2869538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute chorea associated with metoclopramide use.
    Dubow JS; Leikin J; Rezak M
    Am J Ther; 2006; 13(6):543-4. PubMed ID: 17122536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse neurologic effects of metoclopramide.
    Grimes JD; Hassan MN; Preston DN
    Can Med Assoc J; 1982 Jan; 126(1):23-5. PubMed ID: 7059869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine.
    Friedman BW; Esses D; Solorzano C; Dua N; Greenwald P; Radulescu R; Chang E; Hochberg M; Campbell C; Aghera A; Valentin T; Paternoster J; Bijur P; Lipton RB; Gallagher EJ
    Ann Emerg Med; 2008 Oct; 52(4):399-406. PubMed ID: 18006188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind study of lecithin in the treatment of persistent tardive dyskinesia.
    Pérez-Cruet J; Menéndez I; Alvarez-Ghersi J; Falcón JR; Valderrábano O; Castro-Urrutia EC; Ifarraguerri C; Pérez LL
    Bol Asoc Med P R; 1981 Nov; 73(11):531-7. PubMed ID: 6121562
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department.
    Cete Y; Dora B; Ertan C; Ozdemir C; Oktay C
    Cephalalgia; 2005 Mar; 25(3):199-204. PubMed ID: 15689195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.
    Lerner V; Kaptsan A; Miodownik C; Kotler M
    Clin Neuropharmacol; 1999; 22(4):241-3. PubMed ID: 10442256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanocyte-stimulating-hormone release-inhibiting factor-I and tardive dyskinesia.
    Ehrensing RH; Kastin AJ; Larsons PF; Bishop GA
    Dis Nerv Syst; 1977 Apr; 38(4):303-7. PubMed ID: 14814
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral choline administration to patients with tardive dyskinesia.
    Growdon JH; Hirsch MJ; Wurtman RJ; Wiener W
    N Engl J Med; 1977 Sep; 297(10):524-7. PubMed ID: 887103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin E in the treatment of tardive dyskinesia.
    Akhtar S; Jajor TR; Kumar S
    J Postgrad Med; 1993; 39(3):124-6. PubMed ID: 7914238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.
    Patterson D; Abell T; Rothstein R; Koch K; Barnett J
    Am J Gastroenterol; 1999 May; 94(5):1230-4. PubMed ID: 10235199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
    Goetz CG; Damier P; Hicking C; Laska E; Müller T; Olanow CW; Rascol O; Russ H
    Mov Disord; 2007 Jan; 22(2):179-86. PubMed ID: 17094088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine-receptor blockade and tardive dyskinesia.
    Bateman DN; Blain PG
    Lancet; 1979 Sep; 2(8143):641. PubMed ID: 90307
    [No Abstract]   [Full Text] [Related]  

  • 35. Metoclopramide does not influence the frequency of propofol-induced spontaneous movements.
    Lenkovsky F; Robertson BD; Iyer C; Ross L; Ahmed SA; Herazo L; Markin V; Joshi GP
    J Clin Anesth; 2007 Nov; 19(7):530-3. PubMed ID: 18063208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache.
    Corbo J; Esses D; Bijur PE; Iannaccone R; Gallagher EJ
    Ann Emerg Med; 2001 Dec; 38(6):621-7. PubMed ID: 11719739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levetiracetam in tardive dyskinesia.
    Meco G; Fabrizio E; Epifanio A; Morgante F; Valente M; Vanacore N; Di Rosa AE; Morgante L
    Clin Neuropharmacol; 2006; 29(5):265-8. PubMed ID: 16960471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
    Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
    Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Life-threatening tardive dyskinesia caused by metoclopramide.
    Samie MR; Dannenhoffer MA; Rozek S
    Mov Disord; 1987; 2(2):125-9. PubMed ID: 3504264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.